Perry P J, Stambaugh R L, Tsuang M T, Smith R E
J Clin Psychopharmacol. 1981 Sep;1(5):289-96. doi: 10.1097/00004714-198109000-00004.
A study was conducted to assess the feasibility of substituting diazepam for pentobarbital and phenobarbital in sedative-hypnotic tolerance testing and withdrawal of tolerant patients. Nineteen patients potentially dependent on sedative-hypnotics were tolerance tested with either diazepam or pentobarbital and, if tolerant, were withdrawn with diazepam or phenobarbital, respectively. Seventy-eight subjects previously described in the literature with drug dependencies similar to the diazepam and barbiturate groups provided a basis for comparing the diazepam group to untreated patients to determine whether diazepam was able to prevent abstinence symptoms. Withdrawal was successfully completed in all patients. The expected and observed incidence of seizures, delirium, and minor withdrawal for the barbiturate group and seizures and delirium for the diazepam group did not differ significantly, although a large type II error compromised these conclusions. A significant difference was seen between the observed and expected incidence of minor withdrawal symptoms in the diazepam-withdrawn patients.
开展了一项研究,以评估在镇静催眠耐受性测试及对耐受性患者进行撤药时,用 diazepam 替代戊巴比妥和苯巴比妥的可行性。对 19 名可能依赖镇静催眠药的患者用 diazepam 或戊巴比妥进行耐受性测试,若产生耐受性,则分别用 diazepam 或苯巴比妥进行撤药。文献中先前描述的 78 名有类似于 diazepam 和巴比妥类药物组药物依赖情况的受试者为将 diazepam 组与未治疗患者进行比较提供了基础,以确定 diazepam 是否能够预防戒断症状。所有患者均成功完成撤药。巴比妥类药物组癫痫发作、谵妄和轻微戒断的预期发生率与观察到的发生率,以及 diazepam 组癫痫发作和谵妄的预期发生率与观察到的发生率之间,差异均无统计学意义,尽管存在较大的 II 型错误影响了这些结论。在使用 diazepam 撤药的患者中,观察到的轻微戒断症状发生率与预期发生率之间存在显著差异。